J, Z., & Y, C. (2025). Synergistic inhibition of proliferation and induction of apoptosis in oral tongue squamous cell carcinoma by mebendazole and paclitaxel via PI3K/AKT pathway mitigation. Naunyn-Schmiedeberg's archives of pharmacology, 398(5), 5881. https://doi.org/10.1007/s00210-024-03670-y
Chicago Style (17th ed.) CitationJ, Zhang, and Cui Y. "Synergistic Inhibition of Proliferation and Induction of Apoptosis in Oral Tongue Squamous Cell Carcinoma by Mebendazole and Paclitaxel via PI3K/AKT Pathway Mitigation." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 5 (2025): 5881. https://doi.org/10.1007/s00210-024-03670-y.
MLA (9th ed.) CitationJ, Zhang, and Cui Y. "Synergistic Inhibition of Proliferation and Induction of Apoptosis in Oral Tongue Squamous Cell Carcinoma by Mebendazole and Paclitaxel via PI3K/AKT Pathway Mitigation." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 5, 2025, p. 5881, https://doi.org/10.1007/s00210-024-03670-y.